Strategic Direction and Financial Damages Support - Major U.S. University

BACKGROUND

A biotechnology company, with a successful product, licensed the underlying technology from Upstream's client, a major U.S. research university.

Our Analysis

  • Upstream's collaboration with outside counsel determined that additional products marketed by the company had their roots in the university.

  • Upstream provided a detailed financial model, to support the university's claims for additional royalty revenues, based upon:

    • forecasted sales,

    • co-development revenues, and

    • anticipated sub-licenses.

  • Upstream advised the university throughout settlement negotiations and participated in discussions with the company.

Outcome

Ultimately, the company agreed to a substantial, multimillion-dollar settlement with the university.

IP Valuation and MonetizationMARK CHANDLERIP LICENSING, IP MONETIZATION